NYSE:KDMN - Kadmon Holdings, Inc.
$2.30
 $0.04
+1.77%
1:55PM EDT
2019-02-15
Kadmon Holdings, Inc., incorporated on September 15, 2010, is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. The Company's product pipeline consists of KD025, Tesevatinib and KD034. The Company's other products include Ribasphere RibaPak, Ribasphere, Qsymia, Tetrabenazine and Valganciclovir.KD025KD025 is an orally available, selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a molecular target in multiple autoimmune, fibrotic and neurodegenerative diseases. KD025 is indicated for the treatment of Psoriasis Vulgaris, Idiopathic Pulmonary Fibrosis, and Chronic Graft-Versus-Host Disease. The Company is conducting a Phase II randomized, double-blind, placebo-controlled clinical study to evaluate the safety, tolerability and activity of KD025 for Psoriasis Vulgaris, Idiopathic Pulmonary Fibrosis, and Chronic Graft-Versus-Host Disease.TesevatinibTesevatinib is an oral tyrosine kinase inhibitor (TKI) designed to block key molecular drivers of tumor growth, metastases and drug resistance. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KDMN     avg for
industry  
  avg for
sector  
42 stocks weight:  25. 01   0. 00   0. 00  
42 stocks rank:  3. 49 K 1. 86 K 1. 09 K
# analyst opinions:  4. 00   14. 92   14. 43  
mean recommendation:  2. 50   1. 91   1. 93  

quick ratio:  6. 46   5. 37   1. 81  
current ratio:  6. 64   5. 69   2. 19  

target price low:  2. 50   88. 97   117. 82  
target price avg:  2. 82   115. 19   141. 96  
target price high:  3. 48   143. 40   163. 16  
1-yr high:  4. 48   124. 30   142. 77  
last close:  2. 26   101. 85   127. 84  
50-day avg:  2. 28   98. 27   122. 46  
200-day avg:  3. 08   99. 72   122. 70  
1-yr low:  1. 93   78. 19   100. 16  
volume:  507. 64 K 2. 38 M 4. 64 M
50-day avg volume:  825. 20 K 3. 31 M 4. 94 M
200-day avg volume:  804. 50 K 3. 23 M 4. 28 M

1-day return:  2. 73 % 0. 22 % 0. 48 %
this week return:  4. 15 % 1. 77 % 2. 01 %
12-wk return:  -18. 41 % 6. 56 % 3. 33 %
52-wk return:  -54. 13 % -2. 23 % 14. 35 %

enterprise value (EV):  206. 90 M 55. 17 B 104. 51 B
market cap:  251. 11 M 49. 01 B 96. 46 B
EBITDA:  -73. 88 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -2. 80   -91. 79   2. 29  
enterprise/revenue (EV/R):  78. 73   29. 84   23. 39  
total revenue:  2. 63 M 11. 28 B 40. 22 B
total debt:  27. 39 M 13. 73 B 16. 57 B
debt/equity:  21. 41   258. 01   110. 73  
net income (common):  -32. 91 M 2. 37 B 3. 58 B

shares outstanding:  113. 13 M 607. 99 M 1. 22 B
shares:  77. 40 M 605. 53 M 1. 15 B
shares short:  6. 72 M 11. 62 M 12. 55 M
shares short prior month:  7. 21 M 11. 95 M 13. 44 M
short ratio:  4. 52   4. 82   3. 10  
total cash/share:  1. 00   12. 02   11. 46  
total cash:  113. 35 M 7. 41 B 7. 37 B
free cash flow:  -46. 73 M 95. 99 M 2. 04 B
operating cash flow:  -70. 83 M 164. 74 M 3. 04 B

book value:  0. 76   14. 43   28. 26  
price/book:  2. 97   -1. 57   -2. 97  
gross profits:  9. 28 M 8. 28 B 18. 09 B
operating margins:  -2862. 22 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  68. 57 % 49. 33 % 54. 53 %

1-yr max volatility:  18. 00 % --- ---
1-yr mean volatility:  -0. 14 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 37   3. 03   4. 09  
forward EPS:  -0. 59   4. 33   6. 99  
P/E:  -6. 11   6. 11   26. 91  
forward P/E:  -3. 68   8. 38   10. 48  
PE/G:  0. 07   0. 37   5. 61  
growth:  -83. 70 % 683. 72 % 104. 79 %
earnings high:  -0. 12   1. 27   1. 66  
earnings avg:  -0. 19   1. 01   1. 53  
earnings low:  -0. 22   0. 76   1. 40  
revenue high:  2. 10 M 2. 86 B 11. 19 B
revenue avg:  1. 28 M 2. 78 B 10. 84 B
revenue low:  460. 00 K 2. 67 B 10. 64 B
return on assets:  -35. 04 % -3. 27 % 3. 81 %
return on equity:  -46. 39 % 107. 48 % 27. 82 %
revenue growth:  -83. 70 % 648. 36 % 97. 70 %
revenue/share:  0. 03   14. 68   59. 83  

beta (1yr vs S&P500):  0. 94   1. 21   0. 93  
sharpe (1yr):  -0. 60   0. 06   0. 98  

held % insiders:  0. 49 % 6. 46 % 3. 21 %
held % institutions:  73. 99 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : KDMN
.    + 1.133 =         1.133 :: INITIAL WEIGHT
.  + 327.766 =         328.9 :: inverse volume-to-price addition
.  + 248.231 =       577.131 :: spline projection addition
.  - 154.096 =       423.034 :: poor performance penalty
.    x 0.749 =        316.67 :: one-year gains+dividend factor
.    x 4.995 =      1581.827 :: 13 weeks' performance factor
.    x 1.492 =      2360.858 :: industry recommendation factor
.    x 1.412 =      3332.685 :: symbol recommendation factor
.    x 1.639 =       5461.48 :: EV/R factor
.    x 0.996 =       5442.34 :: return on assets factor
.    x 0.995 =      5417.091 :: return on equity factor
.    x 0.992 =       5371.75 :: revenue growth factor
.    x 2.833 =     15220.422 :: current ratio factor
.    x 1.088 =      16556.37 :: quick ratio factor
.    x 1.105 =     18296.392 :: short ratio factor
.     x 2.03 =     37135.432 :: price-to-book factor
.    x 1.041 =     38645.839 :: debt-to-equity factor
.    x 2.137 =      82578.97 :: P/E weight
.    x 1.924 =    158881.798 :: PE/G factor
.    x 1.682 =     267276.16 :: beta factor
.    x 0.601 =    160629.493 :: sharpe factor
.     x 1.33 =    213578.228 :: target low factor
.    x 1.166 =    249016.744 :: target mean factor
.    x 1.073 =    267306.116 :: target high factor
.    x 1.066 =    284844.821 :: industry 12-weeks return
.    x 0.999 =    284621.561 :: overall "drift" factor
.     x 0.82 =    233389.695 :: largest single-day jump factor
.    x 0.067 =     15642.741 :: low price factor
.      x 1.0 =     15643.791 :: factor hist industry gain for week 06
.   cubeRoot =         25.01 :: reduced for readability
.                      25.01 :: FINAL WEIGHT for NYSE:KDMN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org